Image description
The Indian high commission in Dhaka on Tuesday hosts a networking and knowledge-sharing event with the leaders from top Bangladeshi pharmaceutical companies on Tuesday. | Press release photo

The High Commission of India in Bangladesh on Tuesday hosted a networking and knowledge-sharing event, bringing together senior leaders from top Bangladeshi pharmaceutical companies.

The event ‘PharmaConnect’ was organised as part of the High Commission’s broader efforts to deepen bilateral economic engagement in health and pharmaceutical sectors.


The event also highlighted the longstanding complementarities between India and Bangladesh in the pharmaceutical sector.

A press release, issued by the Indian High Commission, read that the event preceded the forthcoming participation of Bangladeshi pharmaceutical companies in CPHI–PMEC India 2025.

The event showcased how India’s globally competitive pharmaceutical industry and Bangladesh’s fast-growing manufacturing capabilities could work together to strengthen supply chains, access new technologies, and deepen commercial linkages.

Addressing the event, the Indian High Commissioner to Bangladesh, Pranay Verma, underscored the strategic importance of the pharmaceutical sector in economic partnership between India and Bangladesh.

He also said that India remained a trusted and reliable partner for Bangladesh—especially in active pharmaceutical ingredient sourcing, process technologies and pharmaceutical machinery—and emphasised that greater collaboration in this sector would not only boost industrial growth but also support affordable and accessible healthcare for millions across the region.

High commissioner Verma added that ‘PharmaConnect’ would help build new business linkages and enhance India-Bangladesh engagement in a future-oriented, innovation-driven framework.

Bangladesh Association of Pharmaceutical Industries president Abdul Muktadir highlighted the country’s expanding global reach in pharmaceuticals and the potential for deeper cooperation with India in areas, including technology transfer, R&D tie-ups and supply-chain integration.

Representatives from the Bangladeshi pharmaceutical industry expressed strong confidence that such engagements would strengthen cross-border collaboration, facilitate technology access, improve supply-chain resilience and open new avenues for trade and investment.

Many Bangladeshi companies would participate in CPHI–PMEC India 2025, scheduled for November 25–27, recognised as one of the largest industry platforms connecting global manufacturers, innovators, investors and policymakers, the release added.